Market Size of UK In Vitro Fertilization Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Historical Data Period | 2019 - 2022 |
CAGR | 7.60 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
UK In Vitro Fertilization Market Analysis
The United Kingdom in vitro fertilization (IVF) market is expected to register a CAGR of 7.6% over the forecast period.
- During the initial phases of the COVID-19 pandemic, many IVF clinics in the United Kingdom temporarily suspended their services or rescheduled non-urgent procedures. This was primarily due to prioritizing resources for COVID-19 patients, reducing the risk of virus transmission, and adhering to government-imposed restrictions. For instance, according to the article published by the National Center for Biotechnology Information (NCBI) in March 2021, the IVF treatment procedures were postponed from April to June months of the pandemic in the United Kingdom. Therefore, the postponement of IVF procedures significantly impacted the market growth initially. However, with the decrease in COVID-19 cases and the uplifting of lockdown restrictions in the country, the IVF market in the country picked up a significant pace and is expected to do the same during the forecast period.
- The major factors driving the market growth include the rising success rate of IVF technology, increasing awareness about IVF procedures, and delayed onset of pregnancy. In addition, the rising number of patients undergoing IVF treatment is also projected to augment market growth during the forecast period. For instance, according to the data released by the Human Fertilisation & Embryology Authority (HFEA) in June 2023, approximately 55,000 patients underwent IVF or donor insemination (DI) treatment at HFEA-licensed fertility centers in the United Kingdom in 2021. Therefore, this substantial number of patients seeking fertility treatments highlights the country's growing demand for assisted reproductive technologies. With advancements in medical technology, increasing awareness, and changing societal trends, the United Kingdom IVF market is poised for growth. This will likely lead to an expansion of fertility centers and the development of innovative treatments to cater to the rising demand, ultimately driving market growth. Furthermore, the surging government initiatives in the United Kingdom are also projected to drive market growth during the forecast period.
- For instance, in July 2022, the Government of the United Kingdom established the Women's Health Strategy in England to tackle the gender health gap, which is likely to drive the growth of the country's IVF market. The strategy aims to address the gender health gap and improve women's reproductive health and access to fertility treatments. By prioritizing women's health and reproductive rights, government regulation is expected to increase awareness and funding for IVF treatments. This could lead to improved accessibility and affordability of IVF services, encouraging more individuals and couples to seek fertility treatments. Consequently, the demand for IVF is likely to increase, driving the growth of the IVF market in the country.
- Therefore, factors such as the rising number of IVF procedures and surging government initiatives to support IVF in the country are expected to drive market growth during the forecast period. However, social stigma and ethical and legal issues associated with in vitro fertilization are estimated to hinder the market growth during the forecast period.
UK In Vitro Fertilization Industry Segmentation
In vitro fertilization is an assistive reproductive technology that involves the process of fertilization by retrieving eggs from the woman's ovaries and fertilizing them with sperm outside of the body in a laboratory environment.
The United Kingdom in vitro fertilization (IVF) market is segmented by product type (reagent and instrument ((imaging systems, incubators, cryosystems, IVF cabinet, ovum aspiration pump, sperm separation systems, micromanipulator systems, and other instruments)) and end-users (fertility clinics, hospitals, and other end-users).
The report offers the value (in USD) for the above segments.
By Product | ||||||||||
Reagent | ||||||||||
|
By End-User | |
Fertility Clinics | |
Hospitals | |
Other End-Users |
UK In Vitro Fertilization Market Size Summary
The United Kingdom's in vitro fertilization (IVF) market is poised for significant growth, driven by factors such as the increasing success rates of IVF technology, heightened awareness of fertility procedures, and societal trends like delayed pregnancy. The market experienced initial setbacks during the COVID-19 pandemic due to the temporary suspension of services, but it has since rebounded as restrictions eased. The demand for assisted reproductive technologies is further bolstered by government initiatives aimed at improving women's reproductive health, such as the Women's Health Strategy in England. This strategy is expected to enhance accessibility and affordability of IVF services, encouraging more individuals to seek fertility treatments. Despite challenges like social stigma and ethical concerns, the market is set to expand, with advancements in medical technology and a growing number of patients undergoing IVF treatments.
The sperm separation systems segment within the IVF market is also expected to see growth, fueled by the adoption of advanced technologies like Zymot, which improve sperm quality and increase IVF success rates. The introduction of such innovative systems is driving competition among fertility clinics, prompting them to invest in state-of-the-art technologies to attract patients. Additionally, the provision of fertility benefits by companies in the UK is increasing access to funding for IVF treatments, further driving market demand. The presence of numerous licensed fertility clinics, coupled with a declining fertility rate, is expected to enhance the accessibility of fertility services and foster competition, thereby supporting the growth of the IVF market in the country.
UK In Vitro Fertilization Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Decrease in Fertility Rate in United Kingdom
-
1.2.2 Increasing Adoption of IVF Procedures
-
1.2.3 Favorable Government Regulations in the Country
-
-
1.3 Market Restraints
-
1.3.1 Social Stigma, Ethical, and Legal Issues Associated with In Vitro Fertilization
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value-USD)
-
2.1 By Product
-
2.1.1 Reagent
-
2.1.2 Instrument
-
2.1.2.1 Imaging Systems
-
2.1.2.2 Incubators
-
2.1.2.3 Cryosystems
-
2.1.2.4 IVF Cabinet
-
2.1.2.5 Ovum Aspiration Pump
-
2.1.2.6 Sperm Separation Systems
-
2.1.2.7 Micromanipulator Systems
-
2.1.2.8 Other Instruments
-
-
-
2.2 By End-User
-
2.2.1 Fertility Clinics
-
2.2.2 Hospitals
-
2.2.3 Other End-Users
-
-
UK In Vitro Fertilization Market Size FAQs
What is the current UK In Vitro Fertilization Market size?
The UK In Vitro Fertilization Market is projected to register a CAGR of 7.60% during the forecast period (2024-2029)
Who are the key players in UK In Vitro Fertilization Market?
Vitrolife , CooperSurgical, Inc., Merck KGaA, IBSA Pharma Ltd and Ferring Pharmaceuticals Ltd are the major companies operating in the UK In Vitro Fertilization Market.